Palvella Therapeutics (PVLA) to Release Earnings on Monday

Palvella Therapeutics (NASDAQ:PVLA) is expected to post its quarterly earnings results before the market opens on Monday, March 31st. Analysts expect Palvella Therapeutics to post earnings of ($0.39) per share for the quarter.

Palvella Therapeutics Trading Up 1.2 %

Palvella Therapeutics stock opened at $28.10 on Friday. Palvella Therapeutics has a 52 week low of $6.20 and a 52 week high of $29.27. The stock has a market cap of $315.31 million, a PE ratio of -2.32 and a beta of 0.54. The stock’s 50-day moving average is $20.24.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on PVLA. Stifel Nicolaus initiated coverage on Palvella Therapeutics in a report on Wednesday. They set a “buy” rating and a $45.00 price objective on the stock. HC Wainwright restated a “buy” rating and issued a $38.00 price target on shares of Palvella Therapeutics in a report on Tuesday, February 11th. Cantor Fitzgerald began coverage on shares of Palvella Therapeutics in a research note on Wednesday, December 18th. They set an “overweight” rating for the company. Jones Trading began coverage on Palvella Therapeutics in a report on Tuesday. They issued a “buy” rating and a $45.00 price target for the company. Finally, Scotiabank started coverage on Palvella Therapeutics in a research report on Friday, March 7th. They issued a “sector outperform” rating and a $50.00 price objective on the stock. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $43.50.

Palvella Therapeutics Company Profile

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc, formerly known as Pieris Pharmaceuticals Inc, is based in WAYNE, Pa.